Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_assertion type Assertion NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_head.
- NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_assertion wasGeneratedBy ECO_0000203 NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_provenance.
- NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_assertion wasDerivedFrom befree-20140225 NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_provenance.
- NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_assertion SIO_000772 22784711 NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_provenance.
- NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_assertion evidence source_evidence_literature NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_provenance.
- NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_assertion description "[Of note, the combination of SPL enforced expression with a SphK1 silencing strategy by further decreasing S1P content made prostate cancer cells even more sensitive to anticancer therapies, suggesting that a dual strategy aimed at stimulating SPL, and inhibiting SphK1 could represent a future approach to sensitize cancer cells to cancer treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568326.RAPj7i__uJX2t2lsbpRxvpCfDT_eZwAla-lvJ1gJ3CGHQ130_provenance.